EP4504202
COMBINATION THERAPIES COMPRISING GDC-6036 AND GDC-0077 FOR THE TREATMENT OF CANCER
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
4.4.2023EP published:
4.2.2026EP application number:
23721096.8
EPO information:
European Patent Register
Max expiry date:
3.4.2043Expiry date:
3.6.2026
Title in English:
COMBINATION THERAPIES COMPRISING GDC-6036 AND GDC-0077 FOR THE TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
4.4.2023EP application
4.2.2026EP Publication
3.6.2026Expires
Owner
Name:
Genentech Inc.Address:
1 DNA Way, South San Francisco, California 94080-4990, US
Inventor
Name:
MERCHANT, Mark AndrewAddress:
San Francisco, California 94080-4990, US
Name:
SCHUTZMAN, Jennifer LeeAddress:
San Francisco, California 94080-4990, US
Name:
SHI, ZhenAddress:
San Francisco, California 94080-4990, US
Name:
SONG, ChunyanAddress:
San Francisco, California 94080-4990, US
Name:
DHARIA, Neekesh VijayAddress:
San Francisco, California 94080-4990, US
Name:
JOO, Stephanie RoyerAddress:
San Francisco, California 94080-4990, US
Priority
Number:
202263328149 PDate:
6.4.2022Country:
US
Classification
Categories:
A61K 31/517, A61K 31/553, A61P 35/00